Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
JCI Insight|March 10, 2025
Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseasesFadhl Alakwaa, Vivek Das, Arindam Majumdar, et al.
Journal of the American Society of Nephrology : JASN|September 5, 2009
Mouse models of diabetic nephropathyFrank C Brosius, Charles E Alpers, Erwin P Bottinger, et al.
Kidney International|March 6, 2021
Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathyLiang Wu, Changjie Liu, Dong-Yuan Chang, et al.
Diabetes|October 27, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney FoundationKatherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2018
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trialKatherine R Tuttle, Frank C Brosius, Sharon G Adler, et al.
Kidney International Reports|January 1, 2019
Soluble ST2 and Galectin-3 and Progression of CKDMariam L Alam, Ronit Katz, Keith A Bellovich, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 30, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney FoundationKatherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
Diabetes|October 9, 2013
Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathyJohanna Guzman, Alexandra N Jauregui, Sandra Merscher-Gomez, et al.
Kidney Medicine|February 2, 2026
Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine ProjectChristine P Limonte, Stephanie Aw, Charles E Alpers, et al.
The Journal of Clinical Investigation|January 13, 2023
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetesJennifer A Schaub, Fadhl M AlAkwaa, Phillip J McCown, et al.
Pageof 11